Carbamoyl-phosphate synthase
AltitudeomicsDB
Protein Official symbol |
CPS1 |
Aliases |
CPS1 |
Chromosomal Location |
2 |
Length |
1500 |
Uniprot ID |
P31327 |
EC number |
6.3.4.16 |
Protein family Information(Pfam) |
PF18302;PF02786;PF02787;PF00988;PF00117;PF02142; |
PDB id |
2YVQ;4UTR;4UTV;4UTX;4UTZ;4UU7;4UU8;4UUA;4UUB;5DOT;5DOU;5OJO;6UEL; |
InterPro ID |
IPR011761;IPR013815;IPR006275;IPR005480;IPR036897;IPR006274;IPR002474;IPR036480;IPR005479;IPR005483;IPR029062;IPR041557;IPR035686;IPR017926;IPR011607;IPR036914;IPR016185; |
dbSNP |
rs375979196 rs1265394565 rs1553509297 rs1553509661 rs767905306 rs752902711 rs1471393474 rs753751183 rs973321068 rs775920437 rs1273594946 rs28940283 rs1047883 rs1047883 rs1472190012 rs149930500 rs201407486 rs760895692 rs778766382 rs772497399 rs772497399 rs371350538 rs1250316045 rs121912592 rs1242028775 rs1553512642 rs777233486 rs1048119191 rs1553512962 rs1275599086 rs1553512974 rs757205958 rs142693704 rs1248368809 rs369061090 rs752339705 rs758724746 rs1553513429 rs201716417 rs201716417 rs201716417 rs1553513861 rs1553513864 rs772782772 rs1553513870 rs1015051007 rs767694281 rs147062907 rs1388955593 rs754706559 rs765484849 rs760714614 rs537170841 rs1191587211 rs955666400 rs534815243 rs121912595 rs757059355 rs121912595 rs1553516442 rs1553516443 rs990390709 rs1404696893 rs749238466 rs1437651658 rs1241423400 rs770471782 rs1392559810 rs1280211937 rs766125631 rs149518280 rs1319489001 rs141373204 rs778117194 rs750670270 rs1047886 rs1047887 rs372645328 rs140578009 rs1245373037 rs1392934477 rs1047891 rs1202306773 rs933813349 rs1553519513 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
ASS1 |
OTC |
0.999 |
CPS1 |
ASS1 |
0.995 |
GLUD2 |
GLUD1 |
0.994 |
CPS1 |
OTC |
0.991 |
NAGS |
OTC |
0.99 |
ASS1 |
CAD |
0.987 |
ASS1 |
NAGS |
0.987 |
GLUL |
GLUD1 |
0.983 |
GLUD2 |
GLUL |
0.978 |
GLS2 |
GLUL |
0.973 |
GLS |
GLUL |
0.972 |
CPS1 |
GLUL |
0.966 |
GLS2 |
GLUD1 |
0.96 |
GLS |
GLUD1 |
0.959 |
GLS |
CAD |
0.951 |
GLUL |
CAD |
0.943 |
CPS1 |
GLUD1 |
0.942 |
GLUD2 |
GLS2 |
0.939 |
GLS2 |
CAD |
0.938 |
NAGS |
GLUD1 |
0.935 |
GLUD2 |
GLS |
0.933 |
CPS1 |
NAGS |
0.929 |
GLUD2 |
NAGS |
0.925 |
CPS1 |
GLUD2 |
0.925 |
CPS1 |
GLS2 |
0.922 |
CPS1 |
GLS |
0.915 |
CPS1 |
CAD |
0.904 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
445 (ASS1) |
1373 (CPS1) |
2747 (GLUD2) |
162417 (NAGS) |
2752 (GLUL) |
27165 (GLS2) |
2744 (GLS) |
5009 (OTC) |
2746 (GLUD1) |
790 (CAD) |
445 (ASS1)
|
1.00
|
0.60
|
0.37
|
0.39
|
0.72
|
0.56
|
0.56
|
0.24
|
0.60
|
0.60
|
1373 (CPS1)
|
0.60
|
1.00
|
0.22
|
0.22
|
0.58
|
0.53
|
0.53
|
0.73
|
0.40
|
0.75
|
2747 (GLUD2)
|
0.37
|
0.22
|
1.00
|
0.38
|
0.20
|
0.21
|
0.21
|
0.20
|
0.84
|
0.43
|
162417 (NAGS)
|
0.39
|
0.22
|
0.38
|
1.00
|
0.20
|
0.21
|
0.21
|
0.24
|
0.35
|
0.31
|
2752 (GLUL)
|
0.72
|
0.58
|
0.20
|
0.20
|
1.00
|
0.63
|
0.63
|
0.17
|
0.49
|
0.49
|
27165 (GLS2)
|
0.56
|
0.53
|
0.21
|
0.21
|
0.63
|
1.00
|
1.00
|
0.20
|
0.42
|
0.42
|
2744 (GLS)
|
0.56
|
0.53
|
0.21
|
0.21
|
0.63
|
1.00
|
1.00
|
0.20
|
0.42
|
0.42
|
5009 (OTC)
|
0.24
|
0.73
|
0.20
|
0.24
|
0.17
|
0.20
|
0.20
|
1.00
|
0.20
|
0.73
|
2746 (GLUD1)
|
0.60
|
0.40
|
0.84
|
0.35
|
0.49
|
0.42
|
0.42
|
0.20
|
1.00
|
0.56
|
790 (CAD)
|
0.60
|
0.75
|
0.43
|
0.31
|
0.49
|
0.42
|
0.42
|
0.73
|
0.56
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
CPS1 |
Toad |
Heart |
- |
3464 m |
33 day |
downregulated |
-2.530414103 |
RNA-seq |
Tibetan Plateau |
Asiatic toad |
1 |
Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - |
28673260 |
Association with TF
TF |
TF Entrez |
Gene |
Gene Entrez |
Type |
PMID |
Database |
EP300 |
2033 |
CPS1 |
1373 |
proximal_filtered |
22955619 |
TRANSFAC |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
1373 |
GO:0006526 |
arginine biosynthetic process |
GOTERM_BP_DIRECT |
1373 |
GO:0032094 |
response to food |
GOTERM_BP_DIRECT |
1373 |
GO:0000050 |
urea cycle |
GOTERM_BP_DIRECT |
1373 |
GO:0043200 |
response to amino acid |
GOTERM_BP_DIRECT |
1373 |
GO:0055081 |
anion homeostasis |
GOTERM_BP_DIRECT |
1373 |
GO:0070365 |
hepatocyte differentiation |
GOTERM_BP_DIRECT |
1373 |
GO:0071400 |
cellular response to oleic acid |
GOTERM_BP_DIRECT |
1373 |
GO:0005543 |
phospholipid binding |
GOTERM_MF_DIRECT |
1373 |
GO:0006541 |
glutamine metabolic process |
GOTERM_BP_DIRECT |
1373 |
GO:0010043 |
response to zinc ion |
GOTERM_BP_DIRECT |
1373 |
GO:0004175 |
dopachrome isomerase activity |
GOTERM_MF_DIRECT |
1373 |
GO:0005524 |
ATP binding |
GOTERM_MF_DIRECT |
1373 |
GO:0032403 |
protein complex binding |
GOTERM_MF_DIRECT |
1373 |
GO:0042493 |
response to drug |
GOTERM_BP_DIRECT |
1373 |
GO:0005743 |
mitochondrial inner membrane |
GOTERM_CC_DIRECT |
1373 |
GO:0005759 |
mitochondrial matrix |
GOTERM_CC_DIRECT |
1373 |
GO:0032496 |
response to lipopolysaccharide |
GOTERM_BP_DIRECT |
1373 |
GO:0060416 |
response to growth hormone |
GOTERM_BP_DIRECT |
1373 |
GO:0043234 |
protein complex |
GOTERM_CC_DIRECT |
1373 |
GO:0009636 |
response to toxic substance |
GOTERM_BP_DIRECT |
1373 |
GO:0042594 |
response to starvation |
GOTERM_BP_DIRECT |
1373 |
GO:0070409 |
carbamoyl phosphate biosynthetic process |
GOTERM_BP_DIRECT |
1373 |
GO:0046872 |
metal ion binding |
GOTERM_MF_DIRECT |
1373 |
GO:0019433 |
triglyceride catabolic process |
GOTERM_BP_DIRECT |
1373 |
GO:0071377 |
cellular response to glucagon stimulus |
GOTERM_BP_DIRECT |
1373 |
GO:0072341 |
14-3-3 protein binding |
GOTERM_MF_DIRECT |
1373 |
GO:0014075 |
response to amine |
GOTERM_BP_DIRECT |
1373 |
GO:0004087 |
biotin carboxylase activity |
GOTERM_MF_DIRECT |
1373 |
GO:0046209 |
nitric oxide metabolic process |
GOTERM_BP_DIRECT |
1373 |
GO:0005509 |
calcium ion binding |
GOTERM_MF_DIRECT |
1373 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process |
GOTERM_BP_DIRECT |
1373 |
GO:0004151 |
cytochrome-c oxidase activity |
GOTERM_MF_DIRECT |
1373 |
GO:0005980 |
glycogen catabolic process |
GOTERM_BP_DIRECT |
1373 |
GO:0006508 |
proteolysis |
GOTERM_BP_DIRECT |
1373 |
GO:0042645 |
mitochondrial nucleoid |
GOTERM_CC_DIRECT |
1373 |
GO:0050667 |
homocysteine metabolic process |
GOTERM_BP_DIRECT |
1373 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
1373 |
GO:0044344 |
cellular response to fibroblast growth factor stimulus |
GOTERM_BP_DIRECT |
1373 |
GO:0071320 |
cellular response to cAMP |
GOTERM_BP_DIRECT |
1373 |
GO:0006807 |
nitrogen compound metabolic process |
GOTERM_BP_DIRECT |
1373 |
GO:0007494 |
midgut development |
GOTERM_BP_DIRECT |
1373 |
GO:0019240 |
citrulline biosynthetic process |
GOTERM_BP_DIRECT |
1373 |
GO:0045909 |
positive regulation of vasodilation |
GOTERM_BP_DIRECT |
1373 |
GO:0004088 |
bisphosphoglycerate mutase activity |
GOTERM_MF_DIRECT |
1373 |
GO:0071548 |
response to dexamethasone |
GOTERM_BP_DIRECT |
1373 |
GO:0004070 |
arylesterase activity |
GOTERM_MF_DIRECT |
1373 |
GO:0016595 |
long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
GOTERM_MF_DIRECT |
1373 |
GO:0005730 |
nucleolus |
GOTERM_CC_DIRECT |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
CPS1 |
1373 |
Condition, Preneoplastic |
C0282313 |
Neoplastic Process |
0.3 |
0.645 |
0.379 |
phenotype |
CPS1 |
1373 |
Comatose |
C0009421 |
Disease or Syndrome |
0.4 |
0.645 |
0.379 |
phenotype |
CPS1 |
1373 |
Psychogenic coma |
C0860634 |
Mental or Behavioral Dysfunction |
0.3 |
0.645 |
0.379 |
disease |
CPS1 |
1373 |
Endotoxemia |
C0376618 |
Finding |
0.3 |
0.645 |
0.379 |
phenotype |
CPS1 |
1373 |
Carbamoyl Phosphate Synthase 1 Deficiency |
C4085580 |
Disease or Syndrome |
0.31 |
0.645 |
0.379 |
disease |
CPS1 |
1373 |
Precancerous Conditions |
C0032927 |
Neoplastic Process |
0.3 |
0.645 |
0.379 |
group |
CPS1 |
1373 |
Persistent Fetal Circulation Syndrome |
C0031190 |
Disease or Syndrome |
0.3 |
0.645 |
0.379 |
disease |
CPS1 |
1373 |
PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO |
C3714958 |
Finding |
0.3 |
0.645 |
0.379 |
phenotype |
CPS1 |
1373 |
Liver Cirrhosis, Experimental |
C0023893 |
Experimental Model of Disease |
0.3 |
0.645 |
0.379 |
disease |
CPS1 |
1373 |
Hyperammonemia |
C0220994 |
Disease or Syndrome |
0.7 |
0.645 |
0.379 |
phenotype |
CPS1 |
1373 |
Carbamoyl-Phosphate Synthase I Deficiency Disease |
C0751753 |
Disease or Syndrome |
0.92 |
0.645 |
0.379 |
disease |
CPS1 |
1373 |
Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency |
C4082171 |
Disease or Syndrome |
0.51 |
0.645 |
0.379 |
disease |
CPS1 |
1373 |
Intellectual Disability |
C3714756 |
Mental or Behavioral Dysfunction |
0.4 |
0.645 |
0.379 |
group |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
CPS1 |
1373 |
CARGLUMIC ACID |
CARGLUMIC ACID |
CHEMBL1201780 |
activator |
CPS1 |
1373 |
CARGLUMIC ACID |
CARGLUMIC ACID |
CHEMBL1201780 |
positive allosteric modulator |